[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 525
Citations 0
Comment & Response
October 25, 2016

Colorectal Cancer Screening Recommendations

Author Affiliations
  • 1Digestive Health Specialists, Tacoma, Washington
  • 2Molecular Pathology Laboratory Network, Maryville, Tennessee

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2016;316(16):1716. doi:10.1001/jama.2016.14915

To the Editor The updated USPSTF recommendation for colorectal cancer screening1 reflects a change in focus, providing a menu of screening choices without expressing a preference for any one option. Although we support patient choice and welcome efforts to improve participation in medical decisions, there are differences in the quality of evidence for these strategies. Reduction in mortality has been demonstrated for fecal occult blood testing and colonoscopy (as well as sigmoidoscopy) in randomized trials and large observational studies.1 In an evidence-based practice environment, these options should be preferred, and a tiered structure of the recommendations would have facilitated the communication of these demonstrated benefits.